[CONSIDERATIONS ON THE THERAPY OF CORONARY INSUFFICIENCY WITH PHENYL-PROPYL-DIPHENYL-PROPYL-AMINE (FPDPA)].
D001713:Biphenyl Compounds; D001774:Blood Chemical Analysis; D001786:Blood Glucose; D001794:Blood Pressure; D002784:Cholesterol / Q000097:blood*; D003327:Coronary Disease; D004562:Electrocardiography; D005080:Exercise Test; D005853:Geriatrics; D006334:Heart Function Tests; D008055:Lipids / Q000097:blood*; D009584:Nitrogen; D010600:Pharmacology; D011299:Prenylamine
D001713:Biphenyl Compounds; D001786:Blood Glucose; D002784:Cholesterol; D008055:Lipids; D009584:Nitrogen; D011299:Prenylamine; C010574:biphenyl
BLOOD CHEMICAL ANALYSIS; BLOOD CHOLESTEROL; BLOOD LIPIDS; BLOOD PRESSURE; BLOOD SUGAR; CORONARY DISEASE; ELECTROCARDIOGRAPHY; EXERCISE TEST; GERIATRICS; HEART FUNCTION TESTS; NITROGEN; PHARMACOLOGY; PRENYLAMINE
CONSIDERAZIONI SULLA TERAPIA DELL'INSUFFICIENZA CORONARICA CON FENIL-PROPILDIFENIL-PROPIL-AMINA (FPDPA)